Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition

Brain Research

Volumn 1315, Issue , 2010, Pages 137-149

  Oikawa, Naoto ^a   Kimura, Nobuyuki ^b   Yanagisawa, Katsuhiko ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Alzheimer disease; Amyloid protein; Argyrophilic tangle; Cynomolgus monkey; Dystrophic neurite; Tau; Tau phosphorylation

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHEMICAL ANALYSIS; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; HISTOCHEMISTRY; HISTOPATHOLOGY; MONKEY; NEOCORTEX; NEURITE; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOLOGY; PRIMATE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TEMPORAL CORTEX;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; BRAIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; NEURITES; NEUROGLIA; NEURONS; OLIGODENDROGLIA; PHOSPHORYLATION; TAU PROTEINS; TEMPORAL LOBE;

ANIMALIA; MACACA FASCICULARIS; PRIMATES;

EID: 75349095224     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.12.005     Document Type: Article

References (75)

1. Bons N., Mestre N., and Petter A. Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus murinus. Neurobiol. Aging 13 (1991) 99-105
2. Bons N., Jallageas V., Silhol S., Mestre-Frances N., Petter A., and Delacourte A. Immunocytochemicaal characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus. C. R. Acad. Sci., III, Sci. Vie 318 (1995) 741-747
3. Bons N., Rieger F., Prudhomme D., Fisher A., and Krause K.H. Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease?. Genes Brain Behav. 5 (2006) 120-130
4. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
5. Braak H., Braak E., and Strothjohann M. Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep. Neurosci. Lett. 171 (1994) 1-4
6. Cork L.C., Powers R.E., Selkoe D.J., Davies P., Geyer J.J., and Price D.L. Neurofibrillary tangles and senile plaques in aged bears. J. Neuropathol. Exp. Neurol. 47 (1988) 629-641
7. Cork L.C., Masters C., Beyreuther K., and Price D.L. Development of senile plaques: relationships of neuronal abnormalities and amyloid deposits. Am. J. Pathol. 137 (1990) 1383-1392
8. Cummings B.J., Su J.H., Cotman C.W., White R., and Russell M.J. β-Amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. Neurobiol. Aging 14 (1993) 547-560
9. Cummings B.J., Head E., Ruehl W., Milgram N.W., and Cotman C.W. The canine as an animal model of human aging and dementia. Neurobiol. Aging 17 (1996) 259-268
10. 40: evidence from cats and dogs. Neurobiol. Aging 17 (1996) 653-659
11. Czasch S., Paul S., and Baumgärtner W. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Neurobiol. Aging 27 (2006) 293-305
12. Delacourte A., Sautière P.E., Wattez A., Mourton-Gilles C., Petter A., and Bons A. Biochemical characterization of tau proteins during cerebral aging of the lemurian primate Microcebus murinus. C. R. Acad. Sci., III Sci. Vie 318 (1995) 85-89
13. Duyckaerts C., Potier M.C., and Delatour B. Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol. 115 (2008) 5-38
14. Flament S., Delacourte A., Hémon B., and Défossez A. Characterization of two pathological tau protein, variants in Alzheimer brain cortices. J. Neurol. Sci. 92 (1989) 133-141
15. Frank S., Clavaguera F., and Tolnay M. Tauopathy models and human neuropathology: similarities and differences. Acta Neuropathol. 115 (2008) 39-53
16. Gearing M., Rebeck G.W., Hyman B.T., Tigges J., and Mirra S.S. Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9382-9386
17. 40 is a major form of β-amyloid in nonhuman primates. Neurobiol. Aging 17 (1996) 903-908
18. Gearing M., Tigges J., Mori H., and Mirra S.S. β-amyloid (Aβ) deposition in the brains of aged orangutans. Neurobiol. Aging 18 (1997) 139-146
19. Geula C., Wu C.K., Saroff D., Lorenzo A., Yuan M., and Yankner B.A. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat. Med. 4 (1998) 827-831
20. Geula C., Nagykery N., and Wu C.K. Amyloid-β deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition. Acta Neuropathol. 103 (2002) 48-58
21. Giannakopoulos P., Silhol S., Jallageas V., Mallet J., Bons N., Bouras C., and Delaère P. Quantitative analysis of tau protein-immunoreactive accumulations and β amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus. Acta Neuropathol. 94 (1997) 131-139
22. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., and Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261 (1986) 6084-6089
23. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
24. Härtig W., Klein C., Brauer K., Schüppel K.F., Arendt T., Brückner G., and Bigl V. Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders. Acta Neuropathol. 100 (2000) 305-312
25. Härtig W., Klein C., Brauer K., Schüppel K.F., Arendt T., Bigl V., and Brückner G. Hyperphosphorylated protein tau is restricted to neurons devoid of perineuronal nets in the cortex of aged bison. Neurobiol. Aging 22 (2001) 25-33
26. Head E., Moffat K., Das P., Sarsoza F., Poon W.W., Landsberg C., Cotman C.W., and Murphy M.P. β-amyloid deposition and tau phosphorylation in clinically characterized aged cats. Neurobiol. Aging 26 (2005) 749-763
27. Hosoda R., Saido T.C., Otvos L., Arai T., Mann D.M.A., Lee V.M., Trojanowski J.Q., and Iwatsubo T. Quantification of modified amyloid β peptides in Alzheimer disease and Down syndrome brains. J. Neuropathol. Exp. Neurol. 57 (1998) 1089-1095
28. Ida N., Hartmann T., Pantel J., Schröder J., Zerfass R., Förstl H., Sandbrink R., Masters C.L., and Beyreuther K. Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J. Biol. Chem. 271 (1996) 22908-22914
29. Ihara Y., Nukina N., Miura R., and Ogawara M. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J. Biochem. 99 (1986) 1807-1810
30. Iwatsubo T., Saido T.C., Mann D.M.N., Lee V.M., and Trojanowski J.Q. Full-length amyloid-β(1-42(43)) and amino-terminally modified and truncated amyloid-β42(43) deposit in diffuse plaques. Am. J. Pathol. 149 (1996) 1823-1830
31. Jeganathan S., Hascher A., Chinnathambi S., Biernat J., Mandelkow E.M., and Mandelkow E. Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation. J. Biol. Chem. 283 (2008) 32066-32076
32. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., and Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21 (2001) 372-381
33. Kiatipattanasakul W., Nakayama H., Yongsiri S., Chotiapisitkul S., Nakamura S., Kojima H., and Doi K. Abnormal neuronal and glial argyrophilic fibrillary structures in the brain of an aged albino cynomolgus monkey (Macaca fascicularis). Acta Neuropathol. 100 (2000) 580-586
34. Kimura N., Tanemura K., Nakamura S., Takashima A., Ono F., Sakakibara I., Ishii Y., Kyuwa S., and Yoshikawa Y. Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains. Biochem. Biophys. Res. Commun. 310 (2003) 303-311
35. Kimura N., Imamura O., Ono F., and Terao K. Aging attenuates dynactin-dynein interaction: down-regulation of dynein causes accumulation of endogenous tau and amyloid precursor protein in human neuroblastoma cells. J. Neurosci. Res. 85 (2007) 2909-2916
36. Kuo Y.M., Beach T.G., Sue L.I., Scott S., Layne K.J., Kokjohn T.A., Kalback W.M., Luehrs D.C., Vishnivetskaya T.A., Abramowski D., Sturchler-Pierrat C., Staufenbiel M., Weller R.O., and Roher A.E. The evolution of Aβ peptide burden in the APP23 transgenic mice: implications for Aβ deposition in Alzheimer disease. Mol. Med. 7 (2001) 609-618
37. Lee V.M., Balin B.J., Otvos L., and Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251 (1991) 675-678
38. Lee V.M., Wang L.J., and Trojanowski J.Q. Purification of paired helical filament tau and normal tau from human brain tissue. Methods Enzymol. 309 (1999) 81-89
39. Lemere C.A., Beierschmitt A., Iglesias M., Spooner E.T., Bloom J.K., Leverone J.F., Zheng J.B., Seabrook T.J., Louard D., Li D., Selkoe D.J., Palmour R.M., and Ervin F.R. Alzheimer's disease Aβ vaccine reduces central nervous system Aβ levels in a non-human primate, the Caribbean velvet. Am. J. Pathol. 165 (2004) 283-297
40. Lemere C.A., Oh J., Stanish H.A., Peng Y., Pepivani I., Fagan A.M., Yamaguchi H., Westmoreland S.V., and Mansfield K.G. Cerebral amyloid-beta protein accumulation with aging in cotton-top-tamarins: a model of early Alzheimer's disease?. Rejuvenation Res. 11 (2008) 321-332
41. Leung E., Guo L., Bu J., Maloof M., Khoury J.E., and Geula C. Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex. Neurobiol. Aging (2009) (electronic publication ahead of print)
42. Martins I.C., Kuperstein I., Wilkinson H., Maes E., Vanbrabant M., Jonckheere W., Van Gelder P., Hartmann D., D'hooge R., De Strooper B., Schymkowitz J., and Rousseau F. Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J. 27 (2008) 224-233
43. Miyasaka T., Morishima-Kawashima M., Ravid R., Kamphorst W., Nagashima K., and Ihara Y. Selective deposition of mutant tau in the FTDP-17 brain affected by the P301L mutation. J. Neuropathol. Exp. Neurol. 60 (2001) 872-884
44. Mori H., Takio K., Ogawara M., and Selkoe D.J. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. Biol. Chem. 267 (1992) 17082-17086
45. Nakamura S., Tamaoka A., Sawamura N., Shoji S., Nakayama H., Ono F., Sakakibara I., Yoshikawa Y., Mori H., Goto N., and Doi K. Carboxyl end-specific monoclonal antibodies to amyloid β protein (Aβ) subtypes (Aβ40 and Aβ42(43)) differentiate Aβ in senile plaques and amyloid angiopathy in brains of aged cynomolgus monkeys. Neurosci. Lett. 201 (1995) 151-154
46. Nakamura S., Nakayama H., Kiatipattanasakul W., Uetsuka K., Uchida K., and Goto N. Senile plaques in very aged cats. Acta Neuropathol. 91 (1996) 437-439
47. Nakamura S., Kiatipattanasakul W., Nakayama H., Ono F., Sakakibara I., Yoshikawa Y., Goto N., and Doi K. Immunohistochemical characteristics of the constituents of senile plaques and amyloid angiopathy in aged cynomolgus monkeys. J. Med. Primatol. 25 (1996) 294-300
48. Nakamura S., Nakayama H., Goto N., Ono F., Sakakibara I., and Yoshikawa Y. Histopathological studies of senile plaques and cerebral amyloidosis in cynomolgus monkeys. J. Med. Primatol. 27 (1998) 244-252
49. Näslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., and Buxbaum J.D. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA 283 (2000) 1571-1577
50. Nelson P.T., Greenberg S.G., and Saper C.B. Neurofibrillary tangles in the cerebral cortex of sheep. Neurosci. Lett. 170 (1994) 187-190
51. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., and LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles. Neuron 39 (2003) 409-421
52. Palazzi X., Switzer R., and Geroge C. Natural occurrence of amyloid-Aβ deposits in the brain of young common marmosets (Callithrix jacchus): a morphological and immunohistochemical evaluation. Vet. Pathol. 43 (2006) 777-779
53. Papaioannou N., Tooten P.C.J., van Ederen A.M., Bohl J.R.E., Rofina J., Tsangaris T., and Gruys E. Immunohistochemical investigation of the brain of aged dog. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid 8 (2001) 11-21
54. Podlisny M.B., Tolan D.R., and Selkoe D.J. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. Am. J. Pathol. 138 (1991) 1423-1435
55. Pugliese M., Mascort J., Mahy N., and Ferrer I. Diffuse beta-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits. Acta Neuropathol. 112 (2006) 175-183
56. Ridley R.M., Baker H.F., Windle C.P., and Cummings R.M. Very long term studies of the sheeding of β-amyloidosis in primates. J. Neural Transm. 113 (2006) 1243-1251
57. Roertgen K.E., Parisi J.E., Clark H.B., Barnes D.L., O'Brien T.D., and Johnson K.H. Aβ-Associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (Gulo gulo). Neurobiol. Aging 17 (1996) 243-247
58. Roher A.E., Lowenson J.D., Clarke S., Wolkow C., Wang R., Cotter R.J., Reardon I.M., Zürcher-Neely H.A., Heinrikson R.L., Ball M.J., and Greenberg B.D. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268 (1993) 3072-3083
59. Rosen R.F., Farberg A.S., Gearing M., Dooyema J., Long P.M., Anderson D.C., Davis-Turak J., Coppola G., Geschwind D.H., Paré J.F., Duong T.Q., Hopkins W.D., Preuss T.M., and Walker L.C. Tauopathy with paired helical filaments in an aged chimpanzee. J. Comp. Neurol. 509 (2008) 259-270
60. N3(pE), in senile plaques. Neuron 14 (1995) 457-466
61. Saido T.C., Yamao-Harigaya W., Iwatsubo T., and Kawashima S. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci. Lett. 215 (1996) 173-176
62. Sawamura N., Tamaoka A., Shoji S., Koo E.H., Walker L.C., and Mori H. Characterization of amyloid β protein species in cerebral amyloid angiopathy of a squirrel monkey by immunocytochemistry and enzyme-linked immunosorbent assay. Brain Res. 764 (1997) 225-229
63. Schultz C., Dehghani F., Hubbard G.B., Thal D.R., Struckhoff G., Braak E., and Braak H. Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons. J. Neuropathol. Exp. Neurol. 59 (2000) 39-52
64. Schultz C., Hubbard G.B., Rüb U., Braak E., and Braak H. Age-related progression of tau pathology in brains of baboons. Neurobiol. Aging 21 (2000) 905-912
65. Schwab C., DeMaggio A.J., Ghoshal N., Binder L.I., Kuret J., and McGeer P.L. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiol. Aging 21 (2000) 503-510
66. Selkoe D.J., Bell D.S., Podlisny M.B., Price D.L., and Cork L.C. Conservation of brain amyloid proteins in aged mammals and human with Alzheimer's disease. Science 235 (1987) 873-877
67. + astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56 (1997) 285-290
68. Tekirian T.L., Saido T.C., Markesbery W.R., Russell M.J., Wekstein D.R., Patel E., and Geddes J.W. N-terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits. J. Neuropathol. Exp. Neurol. 57 (1998) 76-94
69. Uchihara T. Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol. 113 (2007) 483-499
70. Uno H., Alsum P.B., Dong S., Richardson R., Zimbric M.L., Thieme C.S., and Houser W.D. Cerebral amyloid angiopathy and plaques, and visceral amyloidosis in aged macaques. Neurobiol. Aging 17 (1996) 275-281
71. 311) forming beta structure. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5129-5134
72. Walker L.C., Kitt C.A., Schwam E., Buckwald B., Garcia F., Sepinwall J., and Price D.L. Senile plaques in aged squirrel monkeys. Neurobiol. Aging 8 (1987) 291-296
73. Walker L.C., Masters C., Beyreuther K., and Price D.L. Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol. 80 (1990) 381-387
74. Wegiel J., Wisniewski H.M., and Sołtysiak Z. Region- and cell-type-specific pattern of tau phosphorylation in dog brain. Brain Res. 802 (1998) 259-266
75. Wisniewski H.M., Ghetti B., and Terry R.D. Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J. Neuropathol. Exp. Neurol. 32 (1973) 566-584